• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

波兰医学放射学会关于1型神经纤维瘤病患者丛状神经纤维瘤的磁共振成像(MRI)检查建议

Recommendations of the Polish Medical Radiological Society regarding MRI in patients with plexiform neurofibromas in the course of neurofibromatosis type 1.

作者信息

Serafin Zbigniew, Machnikowska-Sokołowska Magdalena, Zawada Elżbieta, Bekiesińska-Figatowska Monika, Hałabuda Agata, Bladowska Marta, Wasilewski Grzegorz, Barańska Dobromiła, Szczurowska Agata, Karwacki Marek, Garus Katarzyna, Styczyński Jan

机构信息

Faculty of Medical Sciences, Bydgoszcz University of Science and Technology, Bydgoszcz, Poland.

Department of Diagnostic Imaging, Radiology and Nuclear Medicine, Faculty of Medical Science in Katowice, Medical University of Silesia in Katowice, Poland.

出版信息

Pol J Radiol. 2025 Jun 3;90:e286-e291. doi: 10.5114/pjr/203005. eCollection 2025.

DOI:10.5114/pjr/203005
PMID:40642196
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12243518/
Abstract

Neurofibromatosis type 1 (NF1) is a genetically determined disorder with a complex clinical picture, including disorders of many systems and organs, that predisposes to the development of various cancers. Approximately 10-30% of patients with NF1 develop plexiform neurofibromas (PN), non-malignant tumours growing along the nerves, tending to infiltrate nerves and nerve plexuses, and may grow into internal organs, the spinal canal, and middle ear, deforming bones and various regions of the body. Magnetic resonance imaging (MRI) plays a key role in the management of individuals during the course of PN, as a screening tool at baseline, for surveillance (in individuals with known PN), to evaluate treatment response, and for preoperative assessment for surgical planning. The practical recommendations presented in this article aim to standardise the protocol for MRI examination of PN in the course of NF1 for the purpose of treatment in a clinical program in Poland. The protocol, covering volumetric MRI examination, imaging schedule, determination of the target change, the technique for measuring the volume of lesions, and suspected malignant transformation, is intended to be the minimum set of MRI sequences and views that must be included in every examination of these patients.

摘要

1型神经纤维瘤病(NF1)是一种由基因决定的疾病,临床表现复杂,累及多个系统和器官,易引发多种癌症。约10%-30%的NF1患者会发展为丛状神经纤维瘤(PN),这是一种沿神经生长的非恶性肿瘤,倾向于浸润神经和神经丛,还可能侵入内部器官、椎管和中耳,导致身体骨骼和各个部位变形。磁共振成像(MRI)在PN病程中对患者的管理起着关键作用,可作为基线筛查工具、用于监测(已知患有PN的患者)、评估治疗反应以及进行术前评估以制定手术方案。本文提出的实用建议旨在规范波兰临床项目中NF1病程中PN的MRI检查方案,以用于治疗。该方案涵盖了MRI容积检查、成像时间表、目标变化的确定、病变体积测量技术以及疑似恶性转化等内容,旨在成为每次对这些患者进行检查时必须包含的最少MRI序列和视图组合。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60ea/12243518/6ecbf105f727/PJR-90-203005-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60ea/12243518/5d25abe24996/PJR-90-203005-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60ea/12243518/6ecbf105f727/PJR-90-203005-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60ea/12243518/5d25abe24996/PJR-90-203005-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60ea/12243518/6ecbf105f727/PJR-90-203005-g002.jpg

相似文献

1
Recommendations of the Polish Medical Radiological Society regarding MRI in patients with plexiform neurofibromas in the course of neurofibromatosis type 1.波兰医学放射学会关于1型神经纤维瘤病患者丛状神经纤维瘤的磁共振成像(MRI)检查建议
Pol J Radiol. 2025 Jun 3;90:e286-e291. doi: 10.5114/pjr/203005. eCollection 2025.
2
- and -Related Osteogenesis Imperfecta与……相关的成骨不全症 (你提供的原文不完整,推测这里可能是想表达“某种因素与成骨不全症相关”,但仅从现有的“- and -Related Osteogenesis Imperfecta”很难准确翻译出完整准确的内容,以上是基于可能情况的翻译 )
3
-Related Overgrowth Spectrum相关过度生长谱系
4
Efficacy and safety of selumetinib in adults with neurofibromatosis type 1 and symptomatic, inoperable plexiform neurofibromas (KOMET): a multicentre, international, randomised, placebo-controlled, parallel, double-blind, phase 3 study.司美替尼治疗1型神经纤维瘤病成人患者及有症状、无法手术的丛状神经纤维瘤的疗效和安全性(KOMET):一项多中心、国际、随机、安慰剂对照、平行、双盲、3期研究
Lancet. 2025 Jun 21;405(10496):2217-2230. doi: 10.1016/S0140-6736(25)00986-9. Epub 2025 Jun 2.
5
Beckwith-Wiedemann Syndrome贝克威思-维德曼综合征
6
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
7
Solitary Plexiform Neurofibroma in the Urachus Associated With von Recklinghausen's Disease.脐尿管内孤立性丛状神经纤维瘤伴冯雷克林霍增氏病
Cureus. 2025 May 21;17(5):e84520. doi: 10.7759/cureus.84520. eCollection 2025 May.
8
Short-Term Memory Impairment短期记忆障碍
9
Contrast-enhanced ultrasound using SonoVue® (sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liver metastases: a systematic review and cost-effectiveness analysis.超声造影使用声诺维®(六氟化硫微泡)与对比增强计算机断层扫描和对比增强磁共振成像在局灶性肝脏病变的特征描述和肝转移检测中的比较:系统评价和成本效益分析。
Health Technol Assess. 2013 Apr;17(16):1-243. doi: 10.3310/hta17160.
10
Clinical Practice Updates: AGA Clinical Practice Update on GI Manifestations and Autonomic or Immune Dysfunction in Hypermobile Ehlers-Danlos Syndrome: Expert Review.临床实践更新:美国胃肠病学会关于可弯曲性埃勒斯-当洛综合征的胃肠道表现及自主神经或免疫功能障碍的临床实践更新:专家综述
Clin Gastroenterol Hepatol. 2025 May 19. doi: 10.1016/j.cgh.2025.02.015.

本文引用的文献

1
ERN GENTURIS tumour surveillance guidelines for individuals with neurofibromatosis type 1.1型神经纤维瘤病患者的ERN GENTURIS肿瘤监测指南
EClinicalMedicine. 2023 Jan 13;56:101818. doi: 10.1016/j.eclinm.2022.101818. eCollection 2023 Feb.
2
Image-Based Differentiation of Benign and Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1.基于图像的1型神经纤维瘤病中良性与恶性周围神经鞘瘤的鉴别
Front Oncol. 2022 May 23;12:898971. doi: 10.3389/fonc.2022.898971. eCollection 2022.
3
Management of neurofibromatosis type 1-associated plexiform neurofibromas.
1 型神经纤维瘤病相关丛状神经纤维瘤的治疗管理。
Neuro Oncol. 2022 Nov 2;24(11):1827-1844. doi: 10.1093/neuonc/noac146.
4
Malignant Peripheral Nerve Sheath Tumors-A Comprehensive Review of Pathophysiology, Diagnosis, and Multidisciplinary Management.恶性周围神经鞘膜瘤——病理生理学、诊断及多学科管理的全面综述
Children (Basel). 2022 Jan 1;9(1):38. doi: 10.3390/children9010038.
5
Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation.修订的 1 型神经纤维瘤病和莱格氏综合征的诊断标准:国际共识建议。
Genet Med. 2021 Aug;23(8):1506-1513. doi: 10.1038/s41436-021-01170-5. Epub 2021 May 19.
6
Selumetinib in Children with Inoperable Plexiform Neurofibromas.索拉非尼治疗不可手术的丛状神经纤维瘤患儿的疗效观察。
N Engl J Med. 2020 Apr 9;382(15):1430-1442. doi: 10.1056/NEJMoa1912735. Epub 2020 Mar 18.
7
Cutaneous neurofibromas in Neurofibromatosis type I: a quantitative natural history study.Ⅰ型神经纤维瘤病中的皮肤神经纤维瘤:一项定量自然病史研究。
Orphanet J Rare Dis. 2018 Feb 7;13(1):31. doi: 10.1186/s13023-018-0772-z.
8
Current whole-body MRI applications in the neurofibromatoses: NF1, NF2, and schwannomatosis.当前全身磁共振成像在神经纤维瘤病中的应用:1型神经纤维瘤病、2型神经纤维瘤病和施万细胞瘤病
Neurology. 2016 Aug 16;87(7 Suppl 1):S31-9. doi: 10.1212/WNL.0000000000002929.
9
Recommendations for imaging tumor response in neurofibromatosis clinical trials.神经纤维瘤病临床试验中肿瘤反应的影像学推荐建议。
Neurology. 2013 Nov 19;81(21 Suppl 1):S33-40. doi: 10.1212/01.wnl.0000435744.57038.af.